<SEC-DOCUMENT>0001139020-25-000201.txt : 20250703
<SEC-HEADER>0001139020-25-000201.hdr.sgml : 20250703
<ACCEPTANCE-DATETIME>20250703104257
ACCESSION NUMBER:		0001139020-25-000201
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250702
FILED AS OF DATE:		20250703
DATE AS OF CHANGE:		20250703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOHARVEST SCIENCES INC.
		CENTRAL INDEX KEY:			0001723464
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42389
		FILM NUMBER:		251104143

	BUSINESS ADDRESS:	
		STREET 1:		1140 - 625 HOWE STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 2T6
		BUSINESS PHONE:		6046221186

	MAIL ADDRESS:	
		STREET 1:		1140 - 625 HOWE STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 2T6

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CANNA-V-CELL SCIENCES INC.
		DATE OF NAME CHANGE:	20191008

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Midnight Star Ventures Corp.
		DATE OF NAME CHANGE:	20171121
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>bhsc_6k.htm
<DESCRIPTION>REPORT
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2025 [PPXC4Y912124VENAK7WG]. www.edgarsuite.com -->
<HEAD>
<TITLE>Report</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><TABLE align=center style='border-collapse:collapse;width:100%;border-bottom:1.5pt solid #000000'><TR><TD valign=top style=width:467.5pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>WASHINGTON, DC 20549</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'><B>FORM 6-K</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>For the month of <B>July 2025</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Commission file number: <B>001-42389</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:16pt Times New Roman;margin:0'><B>BIOHARVEST SCIENCES INC.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Exact name of Registrant as specified in its charter)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Not applicable</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Translation of Registrant&#8217;s name into English)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Address of principal executive offices)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT> Form 20-F&nbsp;<FONT style='font-family:Segoe UI Symbol'>&#9746;</FONT> Form 40-F</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style='border-collapse:collapse;width:100%;border-bottom:1.5pt solid #000000'><TR><TD valign=top style=width:468pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_PART_III /><A name=_ITEM_19._EXHIBITS /><B>SUBMITTED HEREWITH</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Exhibits:</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:71.85pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'><B>Exhibit</B></P>
</TD><TD valign=bottom style=width:396.15pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'><B>Description</B></P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#DBE5F1 style=width:71.85pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'><FONT style='color:#215E99;border-bottom:1px solid #215E99'><A href=bhsc_ex991.htm style=text-decoration:none>99.1</A></FONT></P>
</TD><TD valign=top bgcolor=#DBE5F1 style=width:396.15pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>News Release dated July 2, 2025</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_SIGNATURES /><A name=_Toc169189235 /><A name=_Toc172699253 /><B>SIGNATURES</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'><B>BIOHARVEST SCIENCES INC.</B></P>
</TD></TR>
<TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>(Registrant)</P>
</TD></TR>
<TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>Date: July 3, 2025</P>
</TD><TD valign=top style='width:233.75pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ David Ryan</I></P>
</TD></TR>
<TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:233.75pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Name: David Ryan</P>
</TD></TR>
<TR><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:233.75pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:10pt Times New Roman;margin:0'>Title: Vice-President, Investor Relations &amp; Secretary</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bhsc_ex991.htm
<DESCRIPTION>NEWS RELEASE DATED JULY 2, 2025
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2025 [PPXC4Y912124VENAK7WG]. www.edgarsuite.com -->
<HEAD>
<TITLE>News Release dated July 2, 2025</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD colspan=3 valign=top style=width:468pt><P align=center style='font:10pt Times New Roman;margin:0'><IMG src=bhscex991_1.jpg width=322 height=58 alt='Picture 2' title='Picture 2'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#D9D9D9 style=width:108pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:211.5pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#D9D9D9 style=width:148.5pt><P style='font:11pt Times New Roman;margin:0'>Nasdaq: BHST &#8211;&nbsp;FSE:8MV</P>
</TD></TR>
<TR><TD valign=top style=width:108pt><P style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:211.5pt><P style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:148.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD colspan=3 valign=top bgcolor=#D9D9D9 style=width:468pt><P align=center style='font:14pt Times New Roman;margin:0'><B>BioHarvest Announces Results of Annual General and Special Meeting</B></P>
<P align=center style='font:14pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><B>Rehovot, Israel &#8211; July 2, 2025 - </B><FONT style='color:#467886;border-bottom:1px solid #467886'>BioHarvest Sciences Inc.</FONT> (NASDAQ: BHST) (FSE: 8MV0) (&#8220;BioHarvest&#8221; or the &#8220;Company&#8221;), <FONT style=background-color:#FFFFFF>a company pioneering its patented Botanical Synthesis technology platform, today announced the results of the Company&#8217;s annual general and special meeting of shareholders (the &#8220;AGSM&#8221;) held on June 26, 2025. &nbsp;At the AGSM, shareholders approved all motions put forth, including the passing of a special resolution amending the existing articles of the Company, to divide the board of directors into three classes, with three-year staggered terms (details are described in the Information Circular filed on SEDAR+). The shareholders elected Jake Fiddick and Anne Binder as a Class I directors to hold office until the next annual general meeting. &nbsp;David Tsur and Sharon Malka were elected as Class II directors to hold office until the 2027 annual general meeting, and Zaki Rakib and Vivien Rakib were elected as Class III directors to hold office until the 2028 annual general meeting. The shareholders also approved the appointment of Ziv Haft, Certified Public Accountants (Isr.), a BDO Member Firm, as the auditors of the Company. In addition, the Company&#8217;s Equity Incentive Compensation Plan was confirmed and approved </FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF><B>About BioHarvest Sciences Inc.</B></FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF>BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit </FONT><FONT style='color:#467886;background-color:#FFFFFF;border-bottom:1px solid #467886'>www.bioharvest.com</FONT><FONT style=background-color:#FFFFFF>.</FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF><B>Forward-Looking Statements</B></FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF><I>Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.</I></FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF><I>This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents</I><I>.</I></FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF> </FONT>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF><B>BioHarvest Corporate Contact:</B></FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF>Dave Ryan, VP Investor Relations</FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style=background-color:#FFFFFF>+1 (604) 622-1186</FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0;color:#000000'><FONT style='color:#467886;background-color:#FFFFFF;border-bottom:1px solid #467886'>info@bioharvest.com</FONT></P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bhscex991_1.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 bhscex991_1.jpg
M_]C_X  02D9)1@ ! 0( .P [  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Z F@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1_PEOAO_ *&#2_\ P+C_ ,:L1LT5C?\ "6^&_P#H8-+_ / N/_&C_A+O#?\
MT,&E_P#@7'_C0!LT4U'22-9$8,C %64Y!'J*=0 44UW6-&=V"HHR68X %<?J
MOQ5\$Z-(T=SKUM)*O!2WS*?_ !W(H [*BO-%^._@1GV_;;L#U-JV*Z+1OB/X
M0UZ18K#7K1IFZ12-Y;'Z!L9H ZFBBB@ HK-N_$.BZ?<M;7FKV%O.H!,<UPB,
M,]."<U!_PEOAO_H8-+_\"X_\: -FBL;_ (2WPW_T,&E_^!<?^-'_  EOAO\
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M):Z4&_<V4;87;V+X^\?KQZ5#X:^&/BWQ5;BYT[2REHWW;BX81(WTSR?P%4_
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M8]U]9?Z5;8')*CYE_%<_CBA@<7^SUXL%SI=WX7N7_>VI-Q;9/6-C\P_!N?\
M@5>X5\/^$O$,_A7Q3I^M09/V>4&1!_'&>&7\037VS9W<%_907EM()()XUDC<
M?Q*1D&A 3U\]_M)_\?WA[_KG-_-:^A*^>_VD_P#C^\/?]<YOYK0]@,W]G/\
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M%_R+VF_]>L7_ * *^$_X/PK[LT+_ )%[3?\ KUB_] %=2-B_1113 X+XS?\
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M3&.-4S]I7G QZ5+_ ,-):?\ ]"U=?^!*_P"%%P/<Z*\,_P"&DM/_ .A:NO\
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M#GN!Q^ KE/BM\--2^(%SIDEC?6ML+1)%83AOFW$8Q@'TKTZB@#R;X6_"K5/
M6O7FH7VH6=S'/;>2%@#9!W YY'M7K-%% !6?K>BZ?XATBXTO4[=9[2==K*>H
M]"#V(Z@UH44 ?.-S^SAK/VJ46NN6#6VX^494</M[;L#&:]C\ Z-XC\/:"-+\
M0:C;:AY&%MIHMV\)_=;(YQV/I75T4 %%%% "5A6>ASZ?K\UY;R1BTF!WQG.1
MGGC\:WJ*QJT(57&4MXNZ(E3C)IOH)2T45L6%%%% %+5[-]1T6_L8V5'N+>2)
M6;H"RD G\Z^>1^SAXAQ_R&],_P"^9/\ "OI.B@#YL_X9Q\0_]!O3/^^9/\*/
M^&<?$/\ T&],_P"^9/\ "OI.BE8#YL_X9Q\0_P#0;TS_ +YD_P *#^SAXAQ_
MR&],_P"^9/\ "OI.BBP%#1+&32]!T^PE=7DMK>.%F7H2J@$C\JOT44P/+O&G
MP1T#Q/<2W^GR-I6H2'<S1(&B<^I3L?<8KRK4/@!XSM)&%J;"]C'1HY]A/X,!
M7U-12L!\CK\$O'K/M_LB,>YN8\?SK>TC]GCQ-=2 ZI?6-A%GG83*_P"0P/UK
MZ:HHL!Q?@GX8^'_ P\ZRB>XU!EVO>3X+X[A1T4?2NTHHI@%%%% ' ?%3P'?>
M/M(L+.QN[>V>VN#*S3AL$;2,# ]ZY7X=_!K5_!OC*VUJ[U.QGABCD0QQ!]QW
M*0.HKVFB@ HHHH **** "BBB@ HHHH *YGQ7=3)+96BSM;V\[$2RCL..]=-6
M;J,FF321Z??F-GFY1&_GGM7)C8.=!Q4K7_JWS,:\>:#2=C+'A73)8,VMU*)<
M?+*LN>:V[&":SL$CN;DSN@^:0C%8MQX1L4C:2VN)[9E&00^0*7PW>7.J:/=0
MW#EW0F-93_$"*XL/:A6Y'349-.UG=.QC3M3GR\MF^ST*4(OO%5U-(;B2VT^-
MMJJAP6JVWA1K9EETW4)X)01G><@TSP?=QQ6TVG2D)<12$[6X)'^17237$-O'
MOFE2-,XRQQ4X3#4*]%5JKO)[N^S_ $L*C3A4@ISU??\ K8R/$QDC\-S?O&+C
M8"XX)Y'I5C3V8^&H6))/V?.2>>E5_%1SX=G(Y&5_G4^G?\BS#_U[?TK=_P"^
M27]S]67_ ,OG_A_5G-:%H?\ :VG?:9+^YC8.5PK\<5N6'AM+&]CN1?W,I3/R
M.W!K"\/Z##J>F>?)=SQ,'*[8VP.*Z#3?#\&G7JW*7EQ*P!&UWR.:X,OH7A";
MI?/F_&QAAJ=XQER?.YF^+9;F._T\VKNLOS;0IZG([=ZV=$U>/5K3=]VXCXEC
M]#Z_2LOQ'_R']&_ZZ?U%&LV$^EWHUK35Z'_2(AT8=S_GZUMSU:.)JUHZQ35U
MY6W7H4I3A5G-:JZNOEN&@N[>)M75G8@,< DD#YC3M9OKR\U9-&T^3RF(S-*.
MH'_ZOYU6\+3K=:[J5P@(64;P#VR:4R+I?CB22Y.V*Y3Y9&Z#./ZBL*=5O"0U
MM&4VF_*[)C.]%:Z.6_E=EC_A#H/+R+^Z\_\ YZ;N]:^F6UU:6/E7=U]HD&</
MC&!V'O5W<NW=N&WKG/%,CGBN(C)#(LB<C<IR*]>EA*%&5Z:L[=SKA2IP=XJQ
MP^B:1_; NGEOKF+RI=H"OU_.MRT\+I:W<5P-1NG,;!MK-P?K6%H.C1:J+MY+
MF:'RY< 1MC-=!9>&K>RO([A+VY=HSD*SY!KQL!0YH1FZ5_/F\^QQX>G>,6X?
M.Y6\5W4Z365FL[6]O.Q\V1>.,CO2CPIIDL&;2ZE$N,K*LN>:U-1DTN>6/3[\
MQL\O*(W\\]JS+CPC91QM+:W,]LRC((?@5UXC#N5:<^55%ZV<?ZWZ&LZ3<Y2L
MI?/8V]/MYK6QCAN+@W$JC!D(QFK58/A2_N+[3'^TL7:*38)#_$*WA7I86I"I
M1C.&UCII24H)QV"BBBN@T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J&IZ1::M$$N4.Y
M?NNIPRU?HJ*E.-2+C-73)E%25I;'-?\ ")*P\N34[QX?^>>[BMVRLK?3[9;>
MVC"1CGW)]34_:EK&CA*-%\T(V9$*,(.\49&I>';'4I?.8/%/_P ](S@GZU3C
M\(6ID#7=W<707HKMQ71TE3/ 8:<N>4%<4J%.3NT4[W38+[338L6CAP -G4 =
M*DAM$@L%LU9BBQ[ 3UQBK'8TM;^RAS<]M;6^1IR*]SF1X*L0,"ZN@/9@/Z59
ML?"]K87L=U'<7#-&<@,V0>,5NT5S1R_#0:<8:HRCAJ47=(S[W28;^\M;F1Y%
M>V;<H7H><\U?(!!!&0>HI>U)75&G&+<DM7N:J*3;74S=/T2UTR\GN+<N/.&"
MA/RKSVJ?4-,M=4@\JZCW ?=8<%?H:N4=ZA8>DH.FHKE["5."CRVT.9_X0Z'&
MS^T+OR?^>>ZMNPTZVTVV\BUCV(3DDG))]35OO1VJ*.#H47S4XV9,*-.#O%'-
M'P99%F/VFY&3DX8#^E2VWA.TM;J*X2YN2T;!@&;@XKH*0UG'+L+%W4"5AJ2=
MU$H:GH]IJT86Y0[E^[(IPRUE?\(DC#RY=3O'A_YY[N*Z445=7!8>K+GG'4J5
M"G-WDBO965O86RV]LFR->WJ?4U8HHKHC%12C%62-$DE9!1115#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
